SuperworthCognition Therapeutics shares outstanding CGTX
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 90.6M
- On a year earlier
- +42.3%
- more shares
Cognition Therapeutics had 90.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 42.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 88.4M | +98% |
| FY2024 | 44.6M | +44% |
| FY2023 | 31M | +17% |
| FY2022 | 26.5M | +4831% |
| FY2020 | 537K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 90.6M | +42% | |
| Q1 FY26 | 89.2M | +44% | |
| Q4 FY25 | 88.4M | +98% | |
| Q3 FY25 | 78M | +93% | |
| Q2 FY25 | 63.7M | +59% | |
| Q1 FY25 | 61.8M | +83% | |
| Q4 FY24 | 44.6M | +44% | |
| Q3 FY24 | 40.4M | +33% | |
| Q2 FY24 | 40.1M | +35% | |
| Q1 FY24 | 33.7M | +16% | |
| Q4 FY23 | 31M | +17% | |
| Q3 FY23 | 30.4M | +32% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Cognition Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.